Bolsewig K
*, Willemse EAJ, Sánchez-Juan P, Rábano A, Martinez M, Doecke JD, Bellomo G, Vermunt L, Alcolea D, Halbgebauer S, In 't, Mattsson-Carlgren N, Veverova K, Fowler CJ, Boonkamp L, Koel-simmelink M, Hussainali Z, Ruiters DN, Gaetani L, Toja A, Fortea J, Pijnenburg Y, Lemstra AW, van der Flier WM, Hort J, Otto M, Hansson O, Parnetti L, Masters CL, Lleó A, Teunissen CE, DEL CAMPO M.
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment. Nat Commun 2025; 16(1): 1139.